BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Assy N, Beniashvili Z, Djibre A, Nasser G, Grosovski M, Nseir W. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg(-) chronic hepatitis B patients from inactive chronic carriers. World J Gastroenterol 2009; 15(24): 3025-3031 [PMID: 19554656 DOI: 10.3748/wjg.15.3025]
URL: https://www.wjgnet.com/1007-9327/full/v15/i24/3025.htm
Number Citing Articles
1
Roberta Forlano, Benjamin H Mullish, Ameet Dhar, Robert D Goldin, Mark Thursz, Pinelopi Manousou. Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?World Journal of Hepatology 2021; 13(12): 2104-2112 doi: 10.4254/wjh.v13.i12.2104
2
Menghui Duan, Xiaoling Chi, Huanming Xiao, Xueen Liu, Hui Zhuang. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis BHepatology International 2021; 15(2): 318 doi: 10.1007/s12072-021-10153-2
3
Shahinul Alam, Nooruddin Ahmad, Golam Mustafa, Ananta Shrestha, AKM Khorshed Alam, Mobin Khan. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis BLiver International 2011; 31(6): 824 doi: 10.1111/j.1478-3231.2011.02491.x
4
宇行 刘. Research Progress in Histological Features and Related Influencing Factors of Chronic Hepatitis B Patients with Persistent Normal ALTAdvances in Clinical Medicine 2023; 13(05): 8702 doi: 10.12677/ACM.2023.1351216
5
Kukwah Anthony Tufon, Henry Dilonga Meriki, Damian Nota Anong, Herbert Afegenwi Mbunkah, Theresa Nkuo-Akenji. Genetic diversity, viraemic and aminotransferases levels in chronic infected hepatitis B patients from CameroonBMC Research Notes 2016; 9(1) doi: 10.1186/s13104-016-1916-7
6
Antonio Guardiola-Arévalo, Rafael Gómez Rodríguez, Marta Romero Gutiérrez, Ana Zaida Gómez Moreno, Almudena García Vela, Raquel Sánchez Simón, Cesar Gómez Hernando, Eva María Andrés Esteban. Hepatitis B virus e antigen-negative chronic infection. Treatment based on glutamic pyruvic transaminase and hepatitis B virus deoxyribonucleic acid cut-off valuesGastroenterología y Hepatología (English Edition) 2018; 41(3): 153 doi: 10.1016/j.gastre.2018.03.003
7
Na‐Ling Kang, Ya‐Hong Gao, Meng‐Xin Lin, Lu‐Ying Wu, Xiang‐Yang Ye, Hui‐Ming Lin, Qing‐Fa Ruan, Shuo Lin, Hao‐Hang Liu, Ling‐Ling Huang, Jia‐Ji Jiang, Yu‐Rui Liu, Qi Zheng, Ri‐Cheng Mao, Da‐Wu Zeng. Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriersJournal of Medical Virology 2023; 95(7) doi: 10.1002/jmv.28943
8
AE Atay, G Seven, K Yalcin, S Pasa, H Degertekin. Evaluation of Hepatitis B Viraemia Levels in Patients with HBeAg-negative Chronic Hepatitis B Virus InfectionJournal of International Medical Research 2012; 40(5): 1891 doi: 10.1177/030006051204000529
9
Xianqiong Gong, Jiaen Yang, Jinmo Tang, Chong Gu, Lijian Huang, Ying Zheng, Huiqing Liang, Min Wang, Chuncheng Wu, Yue Chen, Manying Zhang, Zhijian Yu, Qianguo Mao, Antonio Bertoletti. A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis BPLOS ONE 2015; 10(7): e0134532 doi: 10.1371/journal.pone.0134532
10
Geeta Govindaraj. Editorial comments on JACM, Volume 17, Issue 2, July–December 2015Journal of The Academy of Clinical Microbiologists 2024; 18(1): 2 doi: 10.4103/0972-1282.184763
11
Xiao Zhu, Yi Wang, Tao Tao, Dong-Pei Li, Fei-Fei Lan, Wei Zhu, Dan Xie, Hsiang-Fu Kung. A new polymorphism in the <italic>GRP78</italic> is not associated with HBV invasionWorld Journal of Gastroenterology 2009; 15(39): 4958-4961 doi: 10.3748/wjg.15.4958
12
Yesim Ozarda, Ken Sikaris, Thomas Streichert, Joseph Macri. Distinguishing reference intervals and clinical decision limits – A review by the IFCC Committee on Reference Intervals and Decision LimitsCritical Reviews in Clinical Laboratory Sciences 2018; 55(6): 420 doi: 10.1080/10408363.2018.1482256
13
Antonio Guardiola-Arévalo, Rafael Gómez Rodríguez, Marta Romero Gutiérrez, Ana Zaida Gómez Moreno, Almudena García Vela, Raquel Sánchez Simón, Cesar Gómez Hernando, Eva María Andrés Esteban. Infección crónica por virus de la hepatitis B antígeno e negativo. Manejo en función de puntos de corte de glutámico-pirúvica transaminasa y ácido desoxirribonucleico del virus de la hepatitis BGastroenterología y Hepatología 2018; 41(3): 153 doi: 10.1016/j.gastrohep.2017.11.003
14
Beena Philomina, Shabina M. Balakrishnan, KL Sarada Devi, Anitha P Moorkoth, MP Lilabi. Hepatitis B viral load in diagnosing different clinical stages of chronic hepatitis B in a tertiary care hospital in North KeralaJournal of The Academy of Clinical Microbiologists 2024; 18(1): 17 doi: 10.4103/0972-1282.184756
15
Adebayo Laurence Adedeji, Ibrahim Eleha Suleiman, Olubunmi Gloria Ayelagbe. Distribution of polyclonal hypergammaglobulinemia in different phases of chronic hepatitis B infectionLymphoSign Journal 2022; 9(4): 92 doi: 10.14785/lymphosign-2022-0008
16
Bushra Ijaz, Waqar Ahmad, Fouzia T Javed, Sana Gull, Sajida Hassan. Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriersVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-86
17
Baolin Liao, Zhanhui Wang, Siwei Lin, Ying Xu, Junqing Yi, Min Xu, Zuxiong Huang, Ying Zhou, Fuchun Zhang, Jinlin Hou, Sang Hoon Ahn. Significant Fibrosis Is Not Rare in Chinese Chronic Hepatitis B Patients with Persistent Normal ALTPLoS ONE 2013; 8(10): e78672 doi: 10.1371/journal.pone.0078672